Vicki L. Sato's Insider Trades & SAST Disclosures
Vicki L. Sato's most recent trade in Vir Biotechnology Inc was a trade of 10,960 Common Stock done at an average price of $12.5 . Disclosure was reported to the exchange on Jan. 8, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Vicki L. Sato.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 12.52 per share. | 08 Jan 2025 | 10,960 | 1,312,391 (1%) | 0% | 12.5 | 137,219 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 20.91 per share. | 02 Jan 2025 | 3,080 | 107,976 (0%) | 0% | 20.9 | 64,403 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 07 Nov 2024 | 1,020 | 111,056 (0%) | 0% | 30 | 30,600 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 27.07 per share. | 01 Nov 2024 | 3,080 | 112,076 (0%) | 0% | 27.1 | 83,376 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 13 Sep 2024 | 1,020 | 115,156 (0%) | 0% | 30 | 30,600 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 24.99 per share. | 03 Sep 2024 | 2,980 | 116,276 (0%) | 0% | 25.0 | 74,470 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 25.37 per share. | 03 Sep 2024 | 100 | 116,176 (0%) | 0% | 25.4 | 2,537 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 22.12 per share. | 01 Jul 2024 | 2,980 | 119,356 (0%) | 0% | 22.1 | 65,918 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 22.86 per share. | 01 Jul 2024 | 100 | 119,256 (0%) | 0% | 22.9 | 2,286 | Common Stock |
| Allogene Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 95,541 | 95,541 | - | - | Stock Option (Right to buy) | |
| Allogene Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 61,475 | 162,575 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,901 | 17,901 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,967 | 122,336 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 8,000 | 1,323,351 (1%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 20.39 per share. | 15 May 2024 | 1,674 | 116,369 (0%) | 0% | 20.4 | 34,133 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 18.29 per share. | 15 Apr 2024 | 1,666 | 118,043 (0%) | 0% | 18.3 | 30,471 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 20.10 per share. | 15 Mar 2024 | 1,666 | 119,709 (0%) | 0% | 20.1 | 33,487 | Common Stock |
| Denali Therapeutics Inc | Sato L. Vicki | Director | Sale of securities on an exchange or to another person at price $ 18.37 per share. | 15 Feb 2024 | 1,666 | 121,375 (0%) | 0% | 18.4 | 30,604 | Common Stock |
| Denali Therapeutics Inc | L. Sato Vicki | Director | Sale of securities on an exchange or to another person at price $ 18.42 per share. | 16 Jan 2024 | 1,666 | 123,041 (0%) | 0% | 18.4 | 30,688 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 23.39 per share. | 15 Dec 2023 | 1,666 | 124,707 (0%) | 0% | 23.4 | 38,968 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 24.30 per share. | 15 Aug 2023 | 1,666 | 131,371 (0%) | 0% | 24.3 | 40,484 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 29.60 per share. | 17 Jul 2023 | 1,666 | 133,037 (0%) | 0% | 29.6 | 49,314 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 24.66 per share. | 30 Jun 2023 | 18,000 | 1,315,351 (1%) | 0% | 24.7 | 443,916 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 29.98 per share. | 28 Jun 2023 | 1,114 | 134,703 (0%) | 0% | 30.0 | 33,398 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 29.55 per share. | 28 Jun 2023 | 552 | 135,817 (0%) | 0% | 29.6 | 16,312 | Common Stock |
| Allogene Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 59,649 | 101,100 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 23,224 | 23,224 | - | - | Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,649 | 12,649 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,216 | 136,369 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 12,054 | 12,054 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 6,027 | 1,333,351 (1%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 22.59 per share. | 08 Mar 2023 | 17,935 | 1,327,324 (1%) | 0% | 22.6 | 405,062 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 28.35 per share. | 08 Feb 2023 | 17,288 | 1,345,886 (1%) | 0% | 28.4 | 490,160 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 08 Feb 2023 | 627 | 1,345,259 (1%) | 0% | 29 | 18,183 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 25.83 per share. | 09 Jan 2023 | 17,915 | 1,363,174 (1%) | 0% | 25.8 | 462,784 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 25.81 per share. | 08 Dec 2022 | 17,915 | 1,381,089 (1%) | 0% | 25.8 | 462,366 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 27.38 per share. | 08 Nov 2022 | 17,915 | 1,399,004 (1%) | 0% | 27.4 | 490,549 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 20.67 per share. | 10 Oct 2022 | 17,915 | 1,416,919 (1%) | 0% | 20.7 | 370,278 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 21.90 per share. | 08 Sep 2022 | 17,915 | 1,434,834 (1%) | 0% | 21.9 | 392,335 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 30.29 per share. | 08 Aug 2022 | 17,915 | 1,452,749 (1%) | 0% | 30.3 | 542,685 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 28.87 per share. | 08 Jul 2022 | 12,843 | 1,475,736 (1%) | 0% | 28.9 | 370,734 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 29.57 per share. | 08 Jul 2022 | 5,072 | 1,470,664 (1%) | 0% | 29.6 | 149,960 | Common Stock |
| Allogene Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 35,535 | 35,535 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 22,089 | 41,451 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 25.82 per share. | 08 Jun 2022 | 17,415 | 1,489,079 (1%) | 0% | 25.8 | 449,721 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 26.51 per share. | 08 Jun 2022 | 500 | 1,488,579 (1%) | 0% | 26.5 | 13,255 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,959 | 17,959 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 5,986 | 142,149 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 12,810 | 12,810 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 6,405 | 1,509,868 (1%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 23.82 per share. | 23 May 2022 | 3,374 | 1,506,494 (1%) | 0% | 23.8 | 80,369 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 20.62 per share. | 09 May 2022 | 14,541 | 1,503,463 (1%) | 0% | 20.6 | 299,835 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 20.74 per share. | 28 Apr 2022 | 14,093 | 1,521,826 (1%) | 0% | 20.7 | 292,289 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 21.49 per share. | 28 Apr 2022 | 3,822 | 1,518,004 (1%) | 0% | 21.5 | 82,135 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 18 Jan 2022 | 15,173 | 1,535,919 (1%) | 0% | 37.4 | 567,385 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 55.38 per share. | 20 Dec 2021 | 5,200 | 1,554,593 (1%) | 0% | 55.4 | 287,993 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 51.87 per share. | 20 Dec 2021 | 5,173 | 1,561,093 (1%) | 0% | 51.9 | 268,299 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 57.82 per share. | 20 Dec 2021 | 2,401 | 1,551,092 (1%) | 0% | 57.8 | 138,826 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 54.35 per share. | 20 Dec 2021 | 1,300 | 1,559,793 (1%) | 0% | 54.3 | 70,652 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 56.10 per share. | 20 Dec 2021 | 1,100 | 1,553,493 (1%) | 0% | 56.1 | 61,715 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 36.80 per share. | 26 Nov 2021 | 15,174 | 1,566,266 (1%) | 0% | 36.8 | 558,403 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 52.49 per share. | 10 Nov 2021 | 1,006 | 126,827 (0%) | 0% | 52.5 | 52,805 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 53.30 per share. | 10 Nov 2021 | 660 | 126,167 (0%) | 0% | 53.3 | 35,178 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 50.05 per share. | 01 Nov 2021 | 1,666 | 127,833 (0%) | 0% | 50.0 | 83,383 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 39.91 per share. | 19 Oct 2021 | 8,503 | 1,581,440 (1%) | 0% | 39.9 | 339,340 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 39.12 per share. | 19 Oct 2021 | 6,671 | 1,589,943 (1%) | 0% | 39.1 | 260,974 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 52.31 per share. | 17 Sep 2021 | 11,775 | 1,600,013 (1%) | 0% | 52.3 | 615,950 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 53.06 per share. | 17 Sep 2021 | 3,399 | 1,596,614 (1%) | 0% | 53.1 | 180,351 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 53.03 per share. | 15 Sep 2021 | 676 | 130,259 (0%) | 0% | 53.0 | 35,848 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 53.92 per share. | 15 Sep 2021 | 620 | 129,639 (0%) | 0% | 53.9 | 33,430 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 52.28 per share. | 15 Sep 2021 | 230 | 130,935 (0%) | 0% | 52.3 | 12,024 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 54.76 per share. | 15 Sep 2021 | 140 | 129,499 (0%) | 0% | 54.8 | 7,666 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 45.52 per share. | 19 Aug 2021 | 9,045 | 1,611,788 (1%) | 0% | 45.5 | 411,728 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 44.36 per share. | 19 Aug 2021 | 6,129 | 1,620,833 (1%) | 0% | 44.4 | 271,882 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 52.12 per share. | 18 Aug 2021 | 860 | 131,165 (0%) | 0% | 52.1 | 44,823 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 51.26 per share. | 18 Aug 2021 | 806 | 132,025 (0%) | 0% | 51.3 | 41,316 | Common Stock |
| Allogene Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 31,692 | 31,692 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 19,362 | 19,362 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 65.24 per share. | 21 Jul 2021 | 866 | 133,231 (0%) | 0% | 65.2 | 56,498 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 65.78 per share. | 21 Jul 2021 | 400 | 132,831 (0%) | 0% | 65.8 | 26,312 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 64.25 per share. | 21 Jul 2021 | 400 | 134,097 (0%) | 0% | 64.3 | 25,700 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 36.74 per share. | 19 Jul 2021 | 8,811 | 1,633,325 (1%) | 0% | 36.7 | 323,722 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 37.84 per share. | 19 Jul 2021 | 6,363 | 1,626,962 (1%) | 0% | 37.8 | 240,787 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 71.11 per share. | 23 Jun 2021 | 986 | 134,497 (0%) | 0% | 71.1 | 70,110 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 70.20 per share. | 23 Jun 2021 | 680 | 135,483 (0%) | 0% | 70.2 | 47,735 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 21 Jun 2021 | 11,881 | 1,645,429 (1%) | 0% | 46.0 | 546,570 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 46.75 per share. | 21 Jun 2021 | 3,293 | 1,642,136 (1%) | 0% | 46.7 | 153,945 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 6,222 | 6,222 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 2,074 | 136,163 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 64.90 per share. | 26 May 2021 | 894 | 134,861 (0%) | 0% | 64.9 | 58,022 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 65.88 per share. | 26 May 2021 | 732 | 134,129 (0%) | 0% | 65.9 | 48,221 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 66.72 per share. | 26 May 2021 | 40 | 134,089 (0%) | 0% | 66.7 | 2,669 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 6,748 | 6,748 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 3,374 | 1,657,310 (1%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 43.35 per share. | 19 May 2021 | 8,328 | 1,660,782 (1%) | 0% | 43.4 | 361,019 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 44.18 per share. | 19 May 2021 | 5,403 | 1,655,379 (1%) | 0% | 44.2 | 238,705 | Common Stock |
| Vir Biotechnology Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 44.96 per share. | 19 May 2021 | 1,443 | 1,653,936 (1%) | 0% | 45.0 | 64,877 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 63.03 per share. | 28 Apr 2021 | 688 | 135,755 (0%) | 0% | 63.0 | 43,367 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 62.05 per share. | 28 Apr 2021 | 597 | 136,443 (0%) | 0% | 62.0 | 37,042 | Common Stock |
| Denali Therapeutics Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 60.71 per share. | 28 Apr 2021 | 381 | 137,040 (0%) | 0% | 60.7 | 23,129 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges